Get my own profile
Public access
View all13 articles
2 articles
available
not available
Based on funding mandates
Co-authors
- Cécile VoissetInserm Researcher, School of Medicine, Brest, FranceVerified email at univ-brest.fr
- Ibrahim M SayedAssiut University & UMASS LowellVerified email at aun.edu.eg
- Ahmed WahidAssociate Professor of Biochemistry, Alexandria universityVerified email at alexu.edu.eg
- Geert MaertensGeMbiotech, BiocartisVerified email at gembiotech.be
- Florian DouamAssistant Professor - Boston University School of Medicine and NEIDLVerified email at bu.edu
- Shoshana Levyprofessor, stanford universityVerified email at stanford.edu
- Bengrine Abderrahmane Ph.D.CHU-Amiens PicardieVerified email at chu-amiens.fr
- Thibaut VAUSSELINIcahn School of Medicine at Mount SinaiVerified email at mssm.edu
- Naglaa H. ShoukryProfessor of Medicine, Université de Montréal and Centre de Recherche du CHUM (CRCHUM)Verified email at umontreal.ca
- Yalena Amador-CanizaresPost doctoral fellow, University of Saskatchewan, CanadaVerified email at usask.ca
- Thomas BaumertInsermVerified email at unistra.fr
- Francesco NegroProfessor, University Hospitals of GenevaVerified email at hcuge.ch
- L'homme LaurentInserm UMR1011, Lille (France)Verified email at inserm.fr
- Sarah DedeurwaerderVerified email at ulb.ac.be
- Rocco RomagnuoloSenior Scientist at BlueRock TherapeuticsVerified email at bluerocktx.com
- Frédéric MarçonPharmD PhD, CHU d'AmiensVerified email at chu-amiens.fr
- Corey ScipionePostdoctoral Research Fellow, University Health NetworkVerified email at utoronto.ca
Follow
François HELLE
UR UPJV 4294, Agents Infectieux, Résistance et Chimiothérapie, Université de Picardie Jules Verne
Verified email at u-picardie.fr